Battelle’s Post

Gene therapies and nanomedicines are revolutionizing the way we approach disease treatment and prevention. Read more from Anthony Duong Ph.D. as he dives into the convergence of these transformative tools and what to expect from a regulatory perspective. #GeneTherapies #Nanomedicine https://okt.to/Rk1vLu

Gene therapies and nanomedicines are revolutionizing the way we approach disease treatment and prevention. Read more from Anthony Duong Ph.D. as he dives into the convergence of these transformative tools and what to expect from a regulatory perspective. #GeneTherapies #Nanomedicine https://okt.to/AeqsBC

Gene therapies and nanomedicines are revolutionizing the way we approach disease treatment and prevention. The Inside Battelle blog from Anthony Duong explains. #GeneTherapies #Nanomedicine https://okt.to/sTXkwR

Gene therapies and nanomedicines are revolutionizing the way we approach disease treatment and prevention. Our new blog from Anthony Duong Ph.D. dives into the convergence of these transformative tools and what to expect from a regulatory perspective. #GeneTherapies #Nanomedicine https://okt.to/3tgBdI

Gene therapies and nanomedicines are revolutionizing the way we approach disease treatment and prevention. The Inside Battelle blog from Anthony Duong explains. #GeneTherapies #Nanomedicine https://okt.to/3jc6OM

A new era of personalized medicine is upon us. Gene therapies and nanomedicines are at the forefront of this revolution and are changing how we approach disease treatment and prevention. Read this Inside Battelle blog to get smarter on the subject: https://okt.to/aURTtQ

A new era of personalized medicine is upon us. Gene therapies and nanomedicines are at the forefront of this revolution and are changing how we approach disease treatment and prevention. Read this Inside Battelle blog to get smarter on the subject: https://okt.to/kyDB7U

It's a new world and gene therapies and nanomedicines are shaping the future of personalized medicine. Battelle scientists have created the HIT SCAN system, a delivery vehicle platform containing nanocarriers that can serve as components of new genetic drug products. But how do we navigate the regulatory pathways to realize their full potential? In this new Inside Battelle blog, Anthony Duong explores this topic in depth. #GeneticNanomedicines #PrecisionMedicine https://okt.to/IF4BZ5

Demand for #advancedtherapies, such as cell and gene therapies, is growing and won’t stop anytime soon. To get these innovative treatments to patients as quickly as possible, it is critical for #CDMOs to evolve to meet the needs of #pharma and #biotech customers as they work to move medicines from #clinicaltrials to commercialization.   I recently had the opportunity to sit down with [@Clinical Trials Arena] to discuss how our newly opened cold and ultra-cold facility in the #Netherlands will enable our partners in the EU to advance medicines.    Read more from our conversation here: https://lnkd.in/e9j3Rs2e

In the ever-evolving field of cellular and gene therapy, Jared Schuster, HTL(ASCP), CABP from Be The Match highlights a pivotal development in our recent Pharma's Almanac roundtable. Explore detailed insights from Jared and other industry experts in our comprehensive roundtable article answering the question, "What do you think was the single most consequential event or result In pharma/biopharma In 2023?" #CGTDevelopments #FDARegulations #PharmaInnovation